- Home
- NXST vs PTGX Comparison
NXST vs PTGX Comparison
Compare NXST & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXST | PTGX |
|---|---|---|
| Founded | 1996 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.2B |
| IPO Year | 2002 | 2016 |
Fundamental Metrics
Financial Performance| Metric | NXST | PTGX |
|---|---|---|
| Price | $246.67 | $88.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $220.33 | $99.20 |
| AVG Volume (30 Days) | 338.2K | ★ 577.6K |
| Earning Date | 05-29-2026 | 06-01-2026 |
| Dividend Yield | ★ 3.20% | N/A |
| EPS Growth | ★ 122.10 | N/A |
| EPS | ★ 8.57 | N/A |
| Revenue | ★ $5,407,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.31 | $501.99 |
| P/E Ratio | $27.13 | ★ N/A |
| Revenue Growth | ★ 9.61 | N/A |
| 52 Week Low | $141.66 | $35.97 |
| 52 Week High | $254.30 | $96.54 |
Technical Indicators
Market Signals| Indicator | NXST | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 68.29 | 62.57 |
| Support Level | $182.70 | $83.82 |
| Resistance Level | $254.30 | $92.05 |
| Average True Range (ATR) | 9.97 | 3.28 |
| MACD | 0.24 | 0.70 |
| Stochastic Oscillator | 80.18 | 91.81 |
Price Performance
Historical ComparisonAbout NXST Nexstar Media Group Inc.
Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Pending approval, Nexstar's merger with Tegna would bring Nexstar's station total to 259 in 133 markets, reaching 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.